Bristol Myers Squibb (BMYMP) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $10.7 billion.
- Bristol Myers Squibb's Cash & Current Investments fell 171.29% to $10.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.7 billion, marking a year-over-year decrease of 171.29%. This contributed to the annual value of $10.7 billion for FY2025, which is 171.29% down from last year.
- According to the latest figures from Q4 2025, Bristol Myers Squibb's Cash & Current Investments is $10.7 billion, which was down 171.29% from $16.5 billion recorded in Q3 2025.
- Bristol Myers Squibb's Cash & Current Investments' 5-year high stood at $17.0 billion during Q4 2021, with a 5-year trough of $6.7 billion in Q2 2024.
- Over the past 5 years, Bristol Myers Squibb's median Cash & Current Investments value was $11.3 billion (recorded in 2024), while the average stood at $11.5 billion.
- In the last 5 years, Bristol Myers Squibb's Cash & Current Investments plummeted by 4546.15% in 2022 and then skyrocketed by 10446.42% in 2025.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Cash & Current Investments stood at $17.0 billion in 2021, then crashed by 45.46% to $9.3 billion in 2022, then skyrocketed by 32.71% to $12.3 billion in 2023, then fell by 11.57% to $10.9 billion in 2024, then fell by 1.71% to $10.7 billion in 2025.
- Its Cash & Current Investments was $10.7 billion in Q4 2025, compared to $16.5 billion in Q3 2025 and $13.6 billion in Q2 2025.